PolyPeptide Group AG Statistics

Total Valuation

PolyPeptide Group AG has a market cap or net worth of CHF 964.77 million. The enterprise value is 1.03 billion.

Market Cap	964.77M
Enterprise Value	1.03B

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

PolyPeptide Group AG has 32.98 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	n/a
Shares Outstanding	32.98M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-1.38%
Owned by Insiders (%)	4.38%
Owned by Institutions (%)	19.27%
Float	12.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.07
PB Ratio	2.78
P/TBV Ratio	2.92
P/FCF Ratio	30.28
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 244.76, with an EV/FCF ratio of 32.31.

EV / Earnings	-37.44
EV / Sales	3.30
EV / EBITDA	244.76
EV / EBIT	n/a
EV / FCF	32.31

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.32.

Current Ratio	1.59
Quick Ratio	0.64
Debt / Equity	0.32
Debt / EBITDA	26.51
Debt / FCF	3.50
Interest Coverage	-2.48

Financial Efficiency

Return on equity (ROE) is -7.68% and return on invested capital (ROIC) is -3.09%.

Return on Equity (ROE)	-7.68%
Return on Assets (ROA)	-2.34%
Return on Capital (ROIC)	-3.09%
Revenue Per Employee	243,970
Profits Per Employee	-21,533
Employee Count	1,273
Asset Turnover	0.52
Inventory Turnover	1.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.95% in the last 52 weeks. The beta is 1.13, so PolyPeptide Group AG's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+66.95%
50-Day Moving Average	28.97
200-Day Moving Average	30.09
Relative Strength Index (RSI)	54.06
Average Volume (20 Days)	19,236

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PolyPeptide Group AG had revenue of CHF 311.55 million and -27.50 million in losses. Loss per share was -0.84.

Revenue	311.55M
Gross Profit	16.56M
Operating Income	-22.56M
Pretax Income	-30.16M
Net Income	-27.50M
EBITDA	430,381
EBIT	-22.56M
Loss Per Share	-0.84

Full Income Statement

Balance Sheet

The company has 46.67 million in cash and 111.51 million in debt, giving a net cash position of -64.83 million or -1.97 per share.

Cash & Cash Equivalents	46.67M
Total Debt	111.51M
Net Cash	-64.83M
Net Cash Per Share	-1.97
Equity (Book Value)	346.54M
Book Value Per Share	10.51
Working Capital	104.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 82.11 million and capital expenditures -50.24 million, giving a free cash flow of 31.86 million.

Operating Cash Flow	82.11M
Capital Expenditures	-50.24M
Free Cash Flow	31.86M
FCF Per Share	0.97

Full Cash Flow Statement

Margins

Gross margin is 5.32%, with operating and profit margins of -7.24% and -8.83%.

Gross Margin	5.32%
Operating Margin	-7.24%
Pretax Margin	-9.68%
Profit Margin	-8.83%
EBITDA Margin	0.14%
EBIT Margin	-7.24%
FCF Margin	10.23%

Dividends & Yields

PolyPeptide Group AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	0.61%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PolyPeptide Group AG has an Altman Z-Score of 2.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.36
Piotroski F-Score	n/a